,REPOSITORY ID,REPOSITORY LINK,SAMPLE NUMBER,STUDY TITLE,STUDY LINK,ASSAY TYPE,TECHNOLOGY,COUNTRY,DISEASE,DOID,STUDY DESIGN,BODY SITE,PLATFORM,PARTICIPANT FEATURES,AVERAGE SPOTLENGTH,RUN ID,Sample ID,Sample Name,COLLECTION DATE,LIBRARY LAYOUT,LAT LON,SAMPLE TYPE,ETHNICITY,ELO,URBANZATION,REGION,CITYVILLAGE,TARGET AMPLICON,DIET
0,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,478.0,SRR1159635,SRS552195,702-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
1,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159640,SRS552200,131-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
2,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159642,SRS552202,140-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
3,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159645,SRS552206,230-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
4,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159649,SRS552209,271-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
5,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159653,SRS552213,279-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
6,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,484.0,SRR1159658,SRS552218,330-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
7,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159660,SRS552220,348-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
8,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159634,SRS552194,702-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
9,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,493.0,SRR1159639,SRS552199,131-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
10,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159643,SRS552203,201-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
11,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159647,SRS552207,258-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
12,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159656,SRS552216,299-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
13,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159657,SRS552217,330-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
14,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159636,SRS552196,109-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
15,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159637,SRS552197,111-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
16,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159638,SRS552198,111-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
17,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,485.0,SRR1159641,SRS552201,140-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
18,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,493.0,SRR1159644,SRS552204,201-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
19,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159646,SRS552205,230-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
20,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159648,SRS552208,258-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
21,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159650,SRS552210,271-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
22,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159651,SRS552211,277-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
23,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,493.0,SRR1159652,SRS552212,277-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
24,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159654,SRS552214,279-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
25,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159655,SRS552215,299-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
26,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159659,SRS552219,348-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
27,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159546,SRS552149,002-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
28,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159554,SRS552113,456-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
29,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159555,SRS552114,461-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
30,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159556,SRS552115,461-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
31,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159557,SRS552116,474-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
32,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159558,SRS552117,474-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
33,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,493.0,SRR1159559,SRS552118,483-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
34,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159561,SRS552120,495-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
35,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159565,SRS552124,547-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
36,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159569,SRS552128,607-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
37,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159573,SRS552132,611-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
38,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159574,SRS552133,611-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
39,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159581,SRS552140,629-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
40,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,486.0,SRR1159582,SRS552141,629-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
41,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159583,SRS552142,637-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
42,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,485.0,SRR1159584,SRS552143,637-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
43,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159585,SRS552144,669-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
44,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159586,SRS552145,669-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
45,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159587,SRS552146,672-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
46,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159588,SRS552147,672-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
47,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159589,SRS552148,002-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
48,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159590,SRS552150,003-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
49,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159591,SRS552151,003-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
50,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159592,SRS552152,017-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
51,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159599,SRS552159,038-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
52,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159600,SRS552161,041-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
53,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159601,SRS552160,041-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
54,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159602,SRS552162,049-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
55,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159603,SRS552163,049-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
56,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,499.0,SRR1159607,SRS552167,057-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
57,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159608,SRS552168,075-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
58,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,485.0,SRR1159609,SRS552169,075-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
59,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159610,SRS552170,078-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
60,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,493.0,SRR1159611,SRS552171,078-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
61,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159612,SRS552172,083-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
62,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159614,SRS552174,084-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
63,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,486.0,SRR1159616,SRS552176,089-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
64,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,499.0,SRR1159617,SRS552177,089-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
65,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159618,SRS552178,099-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
66,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159619,SRS552179,099-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
67,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,494.0,SRR1159620,SRS552180,100-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
68,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159621,SRS552181,100-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
69,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159622,SRS552182,101-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
70,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159623,SRS552183,101-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
71,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,475.0,SRR1159575,SRS552134,619-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
72,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159576,SRS552135,619-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
73,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159577,SRS552136,623-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
74,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,484.0,SRR1159578,SRS552137,623-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
75,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159579,SRS552138,625-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
76,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159580,SRS552139,625-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
77,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159593,SRS552153,017-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
78,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159594,SRS552154,025-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
79,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159595,SRS552155,025-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
80,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159596,SRS552156,032-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
81,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159597,SRS552157,032-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
82,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159598,SRS552158,038-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
83,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,498.0,SRR1159604,SRS552164,051-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
84,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159605,SRS552165,051-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
85,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159606,SRS552166,057-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
86,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159613,SRS552173,083-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
87,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159615,SRS552175,084-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
88,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,498.0,SRR1159624,SRS552184,105-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
89,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,499.0,SRR1159625,SRS552185,105-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
90,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,486.0,SRR1159626,SRS552186,109-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
91,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159627,SRS552187,677-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
92,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,497.0,SRR1159628,SRS552188,677-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
93,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159629,SRS552189,679-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
94,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159630,SRS552190,679-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
95,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159631,SRS552191,682-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
96,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,496.0,SRR1159632,SRS552192,683-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
97,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,499.0,SRR1159633,SRS552193,683-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
98,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159547,SRS508509,349-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
99,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159548,SRS552107,349-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
100,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,492.0,SRR1159549,SRS552108,436-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
101,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159550,SRS552109,436-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
102,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,491.0,SRR1159551,SRS552110,442-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
103,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,482.0,SRR1159552,SRS552111,442-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
104,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159553,SRS552112,456-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
105,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,486.0,SRR1159560,SRS552119,483-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
106,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,501.0,SRR1159562,SRS552121,495-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
107,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,495.0,SRR1159563,SRS552122,541-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
108,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159564,SRS552123,541-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
109,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,484.0,SRR1159566,SRS552125,547-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
110,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,487.0,SRR1159567,SRS552126,604-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
111,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,488.0,SRR1159568,SRS552127,604-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
112,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,490.0,SRR1159570,SRS552129,607-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
113,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,486.0,SRR1159571,SRS552130,609-1,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
114,PRJNA229922,PRJNA229922,115.0,Effects of vaccination with 10-valent pneumococcal non-typeable haemophilus influenza protein d conjugate vaccine (phid-cv) on the nasopharyngeal microbiome of Kenyan toddlers,26083474.0,Amplicon,Roche,Kenya,Healthy,,Clinical trial,Nasopharynx,454 GS-FLX TITANIUM,Children aged 12–59 months who had been vaccinated with 10-valent pneumococcal non-typeable haemophilus influenzae protein-d conjugate vaccine,489.0,SRR1159572,SRS552131,609-5,11/25/2014,Single,"-3.510651, 39.909328",Nasopharyngeal swab,,,Rural,Malindi,Kilifi,V1-V3,
